Xie Yi, Pittaluga Stefania, Price Susan, Raffeld Mark, Hahn Jamie, Jaffe Elaine S, Rao V Koneti, Maric Irina
Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Haematologica. 2017 Feb;102(2):364-372. doi: 10.3324/haematol.2015.138081. Epub 2016 Oct 20.
Autoimmune lymphoproliferative syndrome is a rare genetic disorder characterized by defective FAS-mediated apoptosis, autoimmune disease, accumulation of mature T-cell receptor alpha/beta positive, CD4 and CD8 double-negative T cells and increased risk of lymphoma. Despite frequent hematologic abnormalities, literature is scarce regarding the bone marrow pathology in autoimmune lymphoproliferative syndrome. We retrospectively reviewed 3l bone marrow biopsies from a cohort of 240 patients with germline FAS mutations. All biopsies were performed for the evaluation of cytopenias or to rule out lymphoma. Clinical information was collected and morphological, immunohistochemical, flow cytometric and molecular studies were performed. Bone marrow lymphocytosis was the predominant feature, present in 74% (23/31) of biopsies. The lymphoid cells showed several different patterns of infiltration, most often forming aggregates comprising T cells in 15 cases, B cells in one and a mixture of T and B cells in the other seven cases. Double-negative T cells were detected by immunohistochemistry in the minority of cases (10/31; 32%); significantly, all but one of these cases had prominent double-negative T-lymphoid aggregates, which in four cases diffusely replaced the marrow space. One case showed features of Rosai-Dorfman disease, containing scattered S-100 cells with emperipolesis and double-negative T cells. No clonal B or T cells were detected by polymerase chain reaction in any evaluated cases. Classical Hodgkin lymphoma was identified in three cases. Our results demonstrate that infiltrates of T cells, or rarely B cells, can be extensive in patients with autoimmune lymphoproliferative syndrome, mimicking lymphoma. A multi-modality approach, integrating clinical, histological, immunohistochemical as well as other ancillary tests, can help avoid this diagnostic pitfall. This study is registered at Clinicaltrials.gov ID # NCT00001350.
自身免疫性淋巴细胞增生综合征是一种罕见的遗传性疾病,其特征为FAS介导的细胞凋亡缺陷、自身免疫性疾病、成熟T细胞受体α/β阳性、CD4和CD8双阴性T细胞积聚以及淋巴瘤风险增加。尽管常出现血液学异常,但关于自身免疫性淋巴细胞增生综合征的骨髓病理学的文献却很稀少。我们回顾性分析了240例种系FAS突变患者队列中的31例骨髓活检。所有活检均用于评估血细胞减少或排除淋巴瘤。收集了临床信息,并进行了形态学、免疫组织化学、流式细胞术和分子研究。骨髓淋巴细胞增多是主要特征,在74%(23/31)的活检中出现。淋巴样细胞表现出几种不同的浸润模式,最常见的是形成聚集物,其中15例由T细胞组成,1例由B细胞组成,另外7例由T细胞和B细胞混合组成。少数病例(10/31;32%)通过免疫组织化学检测到双阴性T细胞;值得注意的是,除1例病例外,所有这些病例均有明显的双阴性T淋巴细胞聚集物,其中4例弥漫性取代了骨髓腔。1例表现为Rosai-Dorfman病特征,含有散在的具有吞噬作用的S-100细胞和双阴性T细胞。在任何评估病例中,通过聚合酶链反应均未检测到克隆性B或T细胞。3例确诊为经典型霍奇金淋巴瘤。我们的结果表明,自身免疫性淋巴细胞增生综合征患者的T细胞浸润或罕见的B细胞浸润可能广泛,类似淋巴瘤。综合临床、组织学、免疫组织化学以及其他辅助检查的多模式方法有助于避免这种诊断陷阱。本研究已在Clinicaltrials.gov注册,注册号为#NCT00001350。